World Vaping Alliance Criticizes EU Report on E-Cigarettes

May.13.2022
World Vaping Alliance Criticizes EU Report on E-Cigarettes
The WVA criticizes EU SCHEER's report on e-cigarettes for ignoring scientific evidence and consumer success stories, causing negative consequences.

A press release from the World Vapers' Alliance (WVA) has emphasized that a recent report from the European Union's Health, Environment and New Risks Scientific Committee (SCHEER) on e-cigarettes is a setback for public health in Europe. This is because the report ignores all scientific evidence that shows e-cigarettes can reduce the harm caused by tobacco, as well as ignoring successful cases of smokers quitting and expert opinions received during the consultation period.

 

Michael Landl, Director of the World Vapers' Alliance (WVA), commented on the report, stating that the misinformation presented will have negative consequences: “This report is a tragedy for public health and will have terrible consequences for smokers and vapers. SCHEER has ignored a wealth of scientific evidence on e-cigarettes, all of which was provided by experts and consumers during consultations earlier this year. They have chosen to ignore it, showing disregard for vapers and common sense.”

 

Patterns of Inaccurate Reporting in the Scheer Report

 

Earlier this year, a renowned expert on reducing the harm caused by tobacco, Dr. Riccardo Polosa, published a paper stating that SCHEER's conclusions lacked sufficient scientific evidence and did not address the health benefits of using electronic cigarettes as a substitute for traditional cigarettes.

 

The SCHEER report on cardiovascular risk assessment contradicts many studies and references data that does not represent current usage patterns. It does not include a report on non-nicotine use. The report makes inaccurate statements about the trend of e-cigarette use and places too much emphasis on the role of flavors in youth initiation without sufficient long-term data.

 

Dr. Riccardo Polosa added that the report did not take into account well-known UK public health data that show e-cigarettes are 95% less harmful than smoking and have recently become the most commonly used tool for quitting smoking.

 

Countries such as the UK and France are actively encouraging smokers to switch to e-cigarettes, a less harmful alternative. If the EU genuinely wants to address smoking-related illnesses, it needs to carefully examine all the evidence. Unfortunately, the SCHEER report is biased against e-cigarettes, and if its recommendations were translated into legislation, it would harm public health.

 

Recommendations on accurate reporting

 

In order to provide accurate reporting, Dr. Riccardo Polosa and his team have drafted some recommendations for SCHEER.

 

(1) The potential health benefits of electronic cigarettes as a replacement for traditional cigarettes.

 

Research on the behavior of switching and substitution between the two.

 

(3) Assessment of cardiovascular risk.

 

Measurement of frequency of use.

 

Non-nicotine usage.

 

The Function of Spices.

 

Conduct thorough research on the effectiveness of quitting smoking.

 

Source: VapingPost

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
North Carolina Adds $1,000 Vape Shop Tax and 21+ Age Verification Requirement
North Carolina Adds $1,000 Vape Shop Tax and 21+ Age Verification Requirement
North Carolina’s new state budget introduces additional vape retail regulations, including a $1,000 tax on vape shops and mandatory age verification requiring customers to be at least 21.
Jul.08
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05